Suchergebnisse - "Tamura, Tomokazu"

PubPharm (93)

1

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

enthalten in: bioRxiv.org | 2024

von Tamura, T. | Yamasoba, D. | Oda, Y. | +23

2

Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study

enthalten in: bioRxiv.org | 2024

von Akahata, W. | Sekida, T. | Nogimori, T. | +18

3

Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

enthalten in: bioRxiv.org | 2024

von Ito, J. | Suzuki, R. | Uriu, K. | +30

4

The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter

enthalten in: Journal of virological methods | 2024

von Suzuki, R. | Kamiyama, A. | Ito, H. | +7

5

Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection

enthalten in: iScience | 2024

von Tamura, T. | Ito, H. | Torii, S. | +15

6

Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution

enthalten in: The Lancet. Microbe | 2024

von Kosugi, Y. | Plianchaisuk, A. | Putri, O. | +77

7

A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation

enthalten in: Journal of virology | 2024

von Tamura, T. | Yamamoto, H. | Ogino, S. | +8

8

Neutralizing immunity against coronaviruses in Tanzanian health care workers

enthalten in: Scientific reports | 2024

von Barabona, G. | Ngare, I. | Kamori, D. | +84

9

Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies : A prospective study

enthalten in: British journal of haematology | 2024

von Ichikawa, T. | Tamura, T. | Takahata, M. | +7

10

Virological characteristics of the SARS-CoV-2 BA.2.86 variant

enthalten in: Cell host & microbe | 2024

von Tamura, T. | Mizuma, K. | Nasser, H. | +34

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]